Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-1 antibody and small-cell lung cancer

Neurocritical Care

Volumn 4, Issue 2, 2006, Pages 137-139

  Lee, Kwan S ^a   Higgins, Michaela J ^a   Patel, Bhavesh M ^a   Larson, Joel S ^a   Rady, Mohamed Y ^a  

^a MAYO CLINIC   (United States)

Author keywords

ANNA 1; anti Hu antibody; Central alveolar hypoventilation; Coma; Paraneoplastic

Indexed keywords

HU ANTIBODY; METHYLPREDNISOLONE;

ACUTE RESPIRATORY FAILURE; AGED; AROUSAL; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN STEM; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; COMA; DISEASE COURSE; ENCEPHALITIS; ENCEPHALOMYELITIS; FEMALE; HUMAN; LUNG ALVEOLUS HYPOVENTILATION; LUNG SMALL CELL CANCER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RESPIRATION CENTER;

AGED; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; BRAIN STEM; CARCINOMA, SMALL CELL; COMA; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS; FATAL OUTCOME; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NERVE TISSUE PROTEINS; NEURONS; PARANEOPLASTIC SYNDROMES; SLEEP APNEA, CENTRAL;

EID: 33646930160     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:4:2:137     Document Type: Article

References (16)

1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349(16):1543-1554.
2. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56(5):715-719.
3. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001;50(3):301-311.
4. Ball JA, Warner T, Reid P, Howard RS, Gregson NA, Rossor MN. Central alveolar hypoventilation associated with paraneoplastic brain-stem encephalitis and anti-Hu antibodies. J Neurol 1994;241(9):561-516.
5. Crino PB, Galetta SL, Sater RA, et al. Clinicopathologic study of paraneoplastic brainstem encephalitis and ophthalmoparesis. J Neuroophthalmol 1996;16(1):44-48.
6. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998;50(3):652-657.
7. Kaplan AM, Itabashi HH. Encephalitis associated with carcinoma. Central hypoventilation syndrome and cytoplasmic inclusion bodies. J Neurol Neurosurg Psychiatry 1974;37(10):1166-1176.
8. Dalmau J, Graus F, Rosenblum MK, PosnerAnti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy JB. A clinical study of 71 patients. Medicine (Baltimore) 1992;71(2):59-72.
9. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53(5):580-587.
10. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 2001;50(3):339-348.
11. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(Pt 7):1481-1494.
12. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004;127(Pt 8):1831-1844.
13. Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, Sakai K. Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 1997;95(6):367-373.
14. Norris S, Rajendiran S, Sheahan K, et al. Noncirrhotic hepatoma presenting with paraneoplastic neurologic manifestations: two cases. Am J Gastroenterol 1997;92(10):1923-1926.
15. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124(Pt 6):1138-1148.
16. Sillevis Smitt P, Grefkens J, de Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002;249(6): 745-753.